Access
Email Verification
Agenda 2023
TBC
0830 - 0930 REGISTRATION AND MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1010 PRIVATE-PUBLIC PARTNERSHIP TO ACCELERATE VACCINE R&D AND MANUFACTURING
- Lessons learned from the COVID-19 pandemic
- Introducing innovative technology platforms
- Ensuring vaccine self-sufficiency for every global region
Anh Wartel
International Vaccine Institute
International Vaccine Institute
1010 - 1040 ACCESS TO VACCINES THROUGH MANUFACTURING TECHNOLOGIES AND INNOVATIONS
- Understanding the importance of equitable access to vaccines
- Learn how existing manufacturing technologies support equitable access to vaccines
- Advances in technological innovations required for equitable access to vaccines
Ramin Sabet Azad
CEPI
CEPI
1040 - 1100 MORNING COFFEE BREAK IN THE EXHIBIT AREA
1100 - 1130 LIGHTNING-FAST AAV, ADENOVIRUS, AND NANOPARTICLE CHARACTERISATION WITH STUNNER
- Get results on capsid titer, empty/full ratio, and aggregation with only 2 uL of sample
- Discover one-step dye-free payload quant and sizing for any nanoparticle
- Learn how Stunner combines UV/Vis, DLS, and SLS to analyze your sample
Nelis Denys
Unchained Labs
Unchained Labs
1130 - 1200 MEET INCREASING VECTOR-BASED VACCINE DEMAND THROUGH INTENSIFICATION STRATEGIES
- Highlighting scale-up challenges for adenovirus-based vaccine
- Upstream process development and manufacturing of adenovirus using a perfusion system
- Introducing an upstream production platform to maximize the yield of next-generation vaccines
Asma Ahmad
Repligen Corporation
Repligen Corporation
1200 - 1330 NETWORKING LUNCH & VISIT THE VACCINE MANUFACTURING EXHIBITION
1330 - 1400 DEVELOPMENT AND SCALE-UP OF LIPID NANOPARTICLES FOR NUCLEIC ACID DELIVERY
- Understanding the need for a given LNP formulation
- Knowing how long it takes for encapsulation prior to dilution helps
- Learn how cost considerations depend on flow rates and mixing technology
Paul Stainton
AstraZeneca
AstraZeneca
1400 - 1430 HOW TO ACCELERATE VACCINE PROCESS DEVELOPMENT – PLATFORM-BASED APPROACH
- Understanding IDTs Warm Base Manufacturing concept to enable pandemic preparedness
- Introducing Platform-based development to accelerate timelines in clinics
- Achieve a deeper understanding of Fast Track Analytics
Mathias Kahl
IDT Biologika
IDT Biologika
1430 - 1500 AFTERNOON COFFEE BREAK IN THE EXHIBIT AREA
1500 - 1530 LOW ENERGY ELECTRON IRRADIATION FOR RAPID GENERATION OF INACTIVATED VACCINES
- Learn how ionizing irradiation is being used for destroying nucleic acids
- Introducing Low Energy Electron Irradiation (LEEI) for normal laboratories and BSL facilities
- Development of industry-scale LEEI devices to produce highly efficient vaccines
Sebastian Ulbert
Fraunhofer Institute for Cell Therapy and Immunology
Fraunhofer Institute for Cell Therapy and Immunology
1530 - 1600 RESERVED PRESENTATION
1600 - 1630 mRNA COVID-19 VACCINE: HOW WE BUILT THE ANALYTICS QUALITY BY DESIGN
- Understand the concepts related to AQbD of a new vaccine based on mRNA platform
- Learn more about Analytical Target profile (ATP) and Critical Quality Attributes (CQAs)
- Looking at the business drivers and technology assessment for more complex methods
Sotiris Missailidis
Bio-Manguinhos/Fiocruz
Bio-Manguinhos/Fiocruz
1630 - 1645 CLOSING REMARKS
1645 - 1730 NETWORKING DRINKS RECEPTION
TBC
0900 - 0930 MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1010 HIGH-YIELD MANUFACTURE OF THERMAL STABLE SUBUNIT VACCINES FOR VIRAL PATHOGEN
- Introducing Vicebio Ltd’s Molecular Clamp Technology to stabilize viral glycoproteins
- Producing mammalian (CHO) cells combined with clamp-specific affinity chromatography
- PoC Phase I clinical trials for RSV and SARS-Cov-2 subunit vaccines
Keith Chappell
University of Queensland
University of Queensland
1010 - 1040 STABILIZATION OF mRNA FORMULATIONS FOR VACCINE AND THERAPEUTIC USE
- Introducing solutions for mRNA modifications and manufacturing
- Evaluating LNP stabilization to overcome current limitations of thermostabilty
- Learn more about mechanostability and aerosol/nasal delivery
Carsten Rudolph
Ethris
Ethris
1040 - 1100 MORNING COFFEE BREAK IN THE EXHIBIT AREA
1100 - 1130 HYBRID MODELLING FOR DIGITAL TWINS OF (BIO)PHARMACEUTICALS PROCESSES
- Understand the behaviour of the in silico replicated process
- Looking at the hybrid modelling for the modelling of (bio)pharmaceutical production processes
- Learn how hybrid modelling renders the development of DTs in the biopharmaceutical industry
Moritz von Stosch
DataHow AG
DataHow AG
1130 - 1200 CLOSED ASEPTIC DOWNSTREAM PROCESSING OF LABILE-ENVELOPED VIRUSES
- Introducing chromatography enables the purification of the measles virus in a closed system
- Looking at flow-through and bind/elute methods can achieve high purity at a high process yield
- Understanding how the process can be performed without the addition of nuclease
Nico Lingg
Austrian Centre of Industrial Biotechnology (acib)
Austrian Centre of Industrial Biotechnology (acib)
1200 - 1230 CELLULAR IMMUNE MONITORING IN GENE THERAPY TRIALS AND ELISPOT ASSAYS
- Looking at the challenges faced during cellular immune response evaluations
- Evaluating B cell responses by microneutralization assays capturing the vector
- Evaluation T cells in recall antigen-specific( the vector or the transgene) ELISPOT assay
Magdalena Tary-Lehmann
ImmunoSpot®
ImmunoSpot®
1230 - 1245 FEEDBACK & RAFFLE DRAW
1245 - 1400 NETWORKING LUNCH
Quick Proposal
Key topics for 2023:
- The fundamentals of vaccine discovery and development to accelerate innovation
Understand vaccine manufacturers' perspective on sustainable vaccine development through next-generation bioinformatics and deep learning techniques. - Exploring innovative and disruptive technologies for biologics and vaccine manufacturing
Analyse emerging trends in potential disruptive technology in vaccine formulation, manufacturing, development, and health care delivery. - Latest research in Quality-by-Design (QbD) analytics for vaccine development
Explore innovations in Quality-by-Design (QbD) approaches in vaccine development and their implementation for the rapid development and deployment of high-volume vaccines. - Leveraging blockchain technology for vaccine manufacturing and supply chain solutions
Evaluate the blockchain-enabled pharmaceutical cold chain and supply chain transparency through blockchain-based traceability. - Advances in vaccine processing, vaccination strategies, and thermostability
Hear from leading vaccine developers on vaccine efficiency, stability monitoring technology, and vaccination strategies. - Case studies, clinical trials, and working with global vaccine manufacturers
Gain insights from leading manufacturers and implement strategies that others in the industry use to ensure successful vaccine delivery.
Sponsorship Opportunities
Join us as a sponsor for this IQ International conference! Reach your target audience, limit competitor influence at the conference and become a keynote speaker, while sharing your company's solutions for this industry.
- Get registration discounts
- Enhance your brand awareness
- Additional marketing opportunities